233 related articles for article (PubMed ID: 30649227)
1. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial.
de Greef BTA; Hoeijmakers JGJ; Geerts M; Oakes M; Church TJE; Waxman SG; Dib-Hajj SD; Faber CG; Merkies ISJ
Brain; 2019 Feb; 142(2):263-275. PubMed ID: 30649227
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.
Labau JIR; Estacion M; Tanaka BS; de Greef BTA; Hoeijmakers JGJ; Geerts M; Gerrits MM; Smeets HJM; Faber CG; Merkies ISJ; Lauria G; Dib-Hajj SD; Waxman SG
Brain; 2020 Mar; 143(3):771-782. PubMed ID: 32011655
[TBL] [Abstract][Full Text] [Related]
4. Yield of peripheral sodium channels gene screening in pure small fibre neuropathy.
Eijkenboom I; Sopacua M; Hoeijmakers JGJ; de Greef BTA; Lindsey P; Almomani R; Marchi M; Vanoevelen J; Smeets HJM; Waxman SG; Lauria G; Merkies ISJ; Faber CG; Gerrits MM
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):342-352. PubMed ID: 30554136
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.
de Greef BT; Geerts M; Hoeijmakers JG; Faber CG; Merkies IS
Trials; 2016 Jul; 17(1):330. PubMed ID: 27439408
[TBL] [Abstract][Full Text] [Related]
6. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
7. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
9. The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.
Han C; Vasylyev D; Macala LJ; Gerrits MM; Hoeijmakers JG; Bekelaar KJ; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):499-505. PubMed ID: 24006052
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.
Shaibani A; Fares S; Selam JL; Arslanian A; Simpson J; Sen D; Bongardt S
J Pain; 2009 Aug; 10(8):818-28. PubMed ID: 19409861
[TBL] [Abstract][Full Text] [Related]
12. Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small-fiber neuropathy.
Eijkenboom I; Sopacua M; Otten ABC; Gerrits MM; Hoeijmakers JGJ; Waxman SG; Lombardi R; Lauria G; Merkies ISJ; Smeets HJM; Faber CG; Vanoevelen JM;
Exp Neurol; 2019 Jan; 311():257-264. PubMed ID: 30316835
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
Huang J; Han C; Estacion M; Vasylyev D; Hoeijmakers JG; Gerrits MM; Tyrrell L; Lauria G; Faber CG; Dib-Hajj SD; Merkies IS; Waxman SG;
Brain; 2014 Jun; 137(Pt 6):1627-42. PubMed ID: 24776970
[TBL] [Abstract][Full Text] [Related]
15. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.
McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG
Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype.
Price N; Namdari R; Neville J; Proctor KJ; Kaber S; Vest J; Fetell M; Malamut R; Sherrington RP; Pimstone SN; Goldberg YP
Clin J Pain; 2017 Apr; 33(4):310-318. PubMed ID: 28266963
[TBL] [Abstract][Full Text] [Related]
17. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
Geerts M; de Greef BTA; Sopacua M; van Kuijk SMJ; Hoeijmakers JGJ; Faber CG; Merkies ISJ
Neurology; 2021 May; 96(20):e2534-e2545. PubMed ID: 33766992
[TBL] [Abstract][Full Text] [Related]
19. The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole.
Lee SI; Hoeijmakers JGJ; Faber CG; Merkies ISJ; Lauria G; Waxman SG
J Neurophysiol; 2020 Feb; 123(2):645-657. PubMed ID: 31851560
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study.
Faber CG; Attal N; Lauria G; Dworkin RH; Freeman R; Dawson KT; Finnigan H; Hajihosseini A; Naik H; Serenko M; Morris CJ; Kotecha M
EClinicalMedicine; 2023 May; 59():101971. PubMed ID: 37152360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
